SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-23-048680
Filing Date
2023-06-13
Accepted
2023-06-13 20:45:08
Documents
2
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1634
2 POWER OF ATTORNEY ea180253ex24_jasper.htm EX-24 6200
  Complete submission text file 0001213900-23-048680.txt   9327
Mailing Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065
Business Address 2200 BRIDGE PKWY SUITE #102 REDWOOD CITY CA 94065 6505491400
Jasper Therapeutics, Inc. (Issuer) CIK: 0001788028 (see all company filings)

IRS No.: 842984849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address
Tucker Edwin Jonathan (Reporting) CIK: 0001792296 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39138 | Film No.: 231012775